Analyzing Rapid Micro Biosystems (NASDAQ:RPID) and Seer (NASDAQ:SEER)
Analyzing Rapid Micro Biosystems (NASDAQ:RPID) and Seer (NASDAQ:SEER)
Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) and Seer (NASDAQ:SEER – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends.
快速微生物系統公司(納斯達克：RFID-GET評級)和SEER(納斯達克：SEER-GET評級)都是小盤股醫療公司，但哪一家更好？我們將根據分析師的建議、盈利能力、估值、機構所有權、收益、風險和股息對這兩家公司進行比較。
Insider & Institutional Ownership
內部人與機構所有權
61.0% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 76.2% of Seer shares are held by institutional investors. 38.0% of Rapid Micro Biosystems shares are held by insiders. Comparatively, 18.0% of Seer shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
機構投資者持有快速微生物系統公司61.0%的股份。相比之下，SEER 76.2%的股份由機構投資者持有。快速微生物系統公司38.0%的股份由內部人士持有。相比之下，Seer 18.0%的股份由內部人士持有。強大的機構持股表明，捐贈基金、對衝基金和大型基金管理公司相信，一隻股票的長期表現將好於大盤。
Valuation and Earnings
估值和收益
This table compares Rapid Micro Biosystems and Seer's revenue, earnings per share (EPS) and valuation.
此表比較了Rapid Micro BiosSystems和Seer的收入、每股收益(EPS)和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Rapid Micro Biosystems | $23.23 million | 2.28 | -$73.52 million | ($1.39) | -0.91 |
| Seer | $6.62 million | 43.53 | -$71.17 million | ($1.45) | -3.17 |
| 總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 市盈率 | |
| 快速微生物生物系統 | 2323萬美元 | 2.28 | -7,352萬美元 | ($1.39) | -0.91 |
| 先知 | 662萬美元 | 43.53 | -7,117萬美元 | ($1.45) | -3.17 |
Analyst Ratings
分析師評級
This is a breakdown of recent ratings and recommmendations for Rapid Micro Biosystems and Seer, as provided by MarketBeat.
這是由MarketBeat提供的對快速微生物生物系統和SEER的最近評級和推薦的細目。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Rapid Micro Biosystems | 0 | 2 | 0 | 0 | 2.00 |
| Seer | 1 | 2 | 0 | 0 | 1.67 |
| 銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
| 快速微生物生物系統 | 0 | 2 | 0 | 0 | 2.00 |
| 先知 | 1 | 2 | 0 | 0 | 1.67 |
Rapid Micro Biosystems presently has a consensus price target of $10.00, indicating a potential upside of 693.65%. Seer has a consensus price target of $9.83, indicating a potential upside of 113.77%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, equities analysts clearly believe Rapid Micro Biosystems is more favorable than Seer.
Rapid Micro BiosSystems目前的共識目標價為10美元，表明潛在上漲693.65%。SEER的普遍目標價為9.83美元，表明潛在上漲113.77%。鑑於Rapid Micro BiosSystems更高的共識評級和更高的可能上行空間，股票分析師顯然認為Rapid Micro BiosSystems比Seer更有利。
Risk & Volatility
風險與波動性
Rapid Micro Biosystems has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Comparatively, Seer has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500.
Rapid Micro BiosSystems的貝塔係數為0.82，這意味着其股價的波動性比標準普爾500指數低18%。相比之下，Seer的貝塔係數為1.46，這意味着其股價的波動性比標準普爾500指數高46%。
Profitability
盈利能力
This table compares Rapid Micro Biosystems and Seer's net margins, return on equity and return on assets.
此表比較了Rapid Micro BiosSystems和Seer的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Rapid Micro Biosystems | -328.18% | -29.41% | -26.52% |
| Seer | -646.27% | -18.80% | -17.32% |
| 淨利潤率 | 股本回報率 | 資產回報率 | |
| 快速微生物生物系統 | -328.18% | -29.41% | -26.52% |
| 先知 | -646.27% | -18.80% | -17.32% |
Summary
摘要
Rapid Micro Biosystems beats Seer on 7 of the 13 factors compared between the two stocks.
快速微生物系統公司在兩隻股票比較的13個因素中有7個超過了Seer。
About Rapid Micro Biosystems
關於快速微生物系統
(Get Rating)
(獲取評級)
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
快速微生物技術公司是一家生命科學技術公司，在北美、歐洲和亞洲提供用於檢測製藥、醫療設備和個人護理產品製造中的微生物污染的產品。公司提供Growth Direct平臺，包括Growth Direct系統、專有耗材、實驗室信息管理系統連接軟件以及全面的客户支持和驗證服務。其平臺可實現生物製劑、疫苗、細胞和基因療法以及無菌注射劑等治療方式的手動微生物質量控制(MQC)測試工作流程的自動化和現代化。該公司還提供安裝和驗證、技術培訓和支持服務。其解決方案被用於環境監測、水測試、生物潤濕和無菌釋放測試應用。該公司前身為基因組圖譜系統公司，並於2007年1月更名為Rapid Micro BiosSystems，Inc.。RAPID微生物生物系統公司成立於2006年，總部設在馬薩諸塞州洛厄爾。
About Seer
關於Seer
(Get Rating)
(獲取評級)
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
SEER，Inc.是一家生命科學公司，致力於開發和商業化產品，以破譯蛋白質組的祕密。它開發了蛋白質圖譜產品套件，這是一種集成的解決方案，包括消耗品、自動化儀器和軟件，使研究人員能夠在治療和診斷研究以及臨牀試驗中進行蛋白質組研究。該公司打算將其產品用於研究目的，包括學術機構、生命科學和研究實驗室，以及用於非診斷和非臨牀目的的生物製藥和生物技術公司。它與探索生命科學有限責任公司達成了一項合作協議。和索爾克生物研究所。該公司前身為Seer Biosciences，Inc.，於2018年7月更名為Seer，Inc.。SEER，Inc.成立於2017年，總部位於加利福尼亞州雷德伍德城。
Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
接受《快速微生物系統日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Rapid Micro BiosSystems和相關公司的最新新聞和分析師評級的每日簡明摘要。